Live Breaking News & Updates on At Moln Ch0256379097
Stay updated with breaking news from At moln ch0256379097. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR . | April 11, 2021 ....